Sunstone Capital
Pre-Seed–Seed
Investment thesis
Sunstone Life Science Ventures seeks to identify and support promising early-stage life science therapeutics innovations that transform scientific discoveries into new pharmaceutical products. The firm focuses on companies across the drug development pipeline, from pre-clinical drug candidates through clinical trials and regulatory approval, aiming to improve patient outcomes while generating returns for investors and supporting healthcare systems across Europe and globally.
Source: firm website, verified Jul 17, 2026.
Frequently asked questions
- What stage does Sunstone Capital invest at?
- Sunstone Capital invests at the Pre-Seed, Seed stages.
- What sectors does Sunstone Capital focus on?
- Sunstone Capital focuses on Biotech, Medical Devices.
Similar investors
Medicxi is a venture capital firm focused on life sciences and healthcare innovation, supporting biotech and medtech companies through their development and commercialization phases.
Osage University Partners invests in breakthrough startups emerging from leading research labs and innovation ecosystems, with a focus on tech and life science companies. The firm manages $800 million and has 150+ portfolio companies across all investment stages from pre-seed to crossover.
Boundary Capital is an early-stage venture capital firm focused on impact investing across Life Science Technologies, Engineering innovations for sustainability, and Software and Data Science platforms that democratize access to skills and knowledge.
Canaan is an early-stage venture capital firm investing in visionaries with transformative ideas across therapeutics, consumer applications, and deep technology sectors.
A deep technology venture capital firm investing in companies solving major global challenges across climate change, human health, defense, security, space, and physically intensive industries.